The primary focus of the current study was to assess the effect of fascin expression on the metabolomics profile of the MDA-MB-231 breast cancer cell line in order to identify potential candidates for further investigation and hypothesis generation. The gene discussed is FSCN1; the disease is breast carcinoma.